HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development

PLoS Pathog. 2014 May 22;10(5):e1004073. doi: 10.1371/journal.ppat.1004073. eCollection 2014 May.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS Vaccines / therapeutic use*
  • Antibodies, Neutralizing / genetics
  • Antibodies, Neutralizing / immunology
  • Antibodies, Neutralizing / therapeutic use*
  • Autoantibodies / immunology
  • Drug Discovery* / methods
  • Drug Discovery* / standards
  • HIV Antibodies / immunology
  • HIV Envelope Protein gp41 / immunology*
  • HIV Infections / genetics
  • HIV Infections / immunology
  • HIV Infections / prevention & control*
  • HIV-1 / immunology*
  • Humans
  • Immune Tolerance
  • Mutation

Substances

  • AIDS Vaccines
  • Antibodies, Neutralizing
  • Autoantibodies
  • HIV Antibodies
  • HIV Envelope Protein gp41